Se espera que el mercado de tecnología de perfusión médica alcance los 962,60 millones de dólares en 2027, frente a los 707,10 millones de dólares de 2019. Se estima que el mercado crecerá a una tasa compuesta anual del 4,1 % de 2020 a 2027.
El alcance del mercado de tecnología de perfusión médica incluye técnica, tipo de órgano, componente y región. El mercado de tecnología de perfusión médica, según la región, está segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y América del Sur y Central. El informe ofrece información y un análisis en profundidad del mercado de tecnología de perfusión médica haciendo hincapié en varios parámetros, como tendencias del mercado, avances tecnológicos, dinámica del mercado y análisis del panorama competitivo de los principales actores del mercado en todo el mundo. También incluye análisis de impacto de COVID-19 en todas las regiones.
regiones lucrativas para el mercado de tecnología de perfusión médicaPerspectivas del mercado
Instrumentos de perfusión para actividades de investigación basadas en células
El aumento de las enfermedades crónicas y las ventajas de las aplicaciones de la biotecnología están impulsando ampliamente las actividades de investigación basadas en células. Los ensayos basados en células desempeñan un papel vital en la comprensión de diversos desafíos de la biología de los organismos vivos, como la señalización celular, la proliferación, la apoptosis, la genética celular, la neurología y el cáncer.
Los ensayos basados en células son Se lleva a cabo ampliamente en industrias farmacéuticas, biotecnológicas, institutos de investigación e institutos de investigación académicos. Las industrias farmacéutica y biofarmacéutica utilizan ensayos basados en células para comercializar eficientemente un fármaco.
Los ensayos basados en células también se llevan a cabo ampliamente por organizaciones de investigación por contrato para estudios de ensayos clínicos y otros procesos. Las enfermedades crónicas como el cáncer y otros estudios relacionados con la genética están acelerando la demanda de estudios basados en células. Por ejemplo, Charles River ofrece servicios para ensayos basados en células primarias humanas. Según un artículo publicado por la empresa, es probable que los avances en los ensayos basados en células continúen en el futuro. Además, la empresa afirma que los ensayos basados en células son útiles en el descubrimiento de fármacos, ya que la correlación in vitro e in vivo desempeña un papel vital en el desarrollo de fármacos. Por lo tanto, es probable que las crecientes actividades de investigación basadas en células impulsen el mercado de tecnología de perfusión médica durante el período de pronóstico.
Información basada en técnicas
Basado en la técnica, el mercado de tecnología de perfusión médica se segmenta en perfusión de máquina hipotérmica y perfusión de máquina normotérmica. El segmento de perfusión de máquinas hipotérmicas tuvo una mayor participación de mercado en 2019. Sin embargo, se estima que el segmento de perfusión de máquinas normotérmicas registrará una CAGR más alta del 4,4% en el mercado durante el período de pronóstico.
Global Mercado de tecnología de perfusión médica, por técnica: 2019 y 2027
Información basada en el tipo de órgano
Según el tipo de órgano, el mercado de tecnología de perfusión médica se segmenta en corazón, pulmón y riñón. y el hígado. El segmento de riñón tuvo la mayor participación del mercado en 2019. Sin embargo, se estima que el segmento del corazón registrará la CAGR más alta del mercado del 4,8 % durante el período de pronóstico.
Basado en componentes Información
Según los componentes, el mercado de tecnología de perfusión médica se segmenta en bombas de perfusión, oxigenadores, máquinas de circulación extracorpórea, sistemas de monitorización, cánulas y otros. En 2019, el segmento de oxigenadores tuvo la mayor participación de mercado, por componente. Además, también se espera que el segmento crezca al ritmo más rápido durante los próximos años debido al creciente número de cirugías cardiovasculares, trasplantes de hígado y trasplantes de riñón.
Ideas estratégicas
Estrategias inorgánicas como asociaciones y fusiones & Las empresas suelen adoptar adquisiciones para satisfacer la demanda cambiante de los clientes y mantener su marca en todo el mundo. Los actores del mercado que operan en el mercado de tecnología de perfusión médica también adoptan estrategias orgánicas, como el lanzamiento y la expansión de productos, para ampliar su presencia y cartera de productos en todo el mundo, así como para satisfacer la creciente demanda.
< p>Por técnica- Perfusión con máquina hipotérmica
- Perfusión con máquina normotérmica
Por tipo de órgano
- Corazón
- Pulmón
- Riñón
- Hígado
- Otros
Por componente
- Bombas de perfusión
- Oxigenadores
- Máquinas de circulación extracorpórea
- Sistemas de monitorización
- Cánulas < li>Otros
Por geografía
- América del Norte
- Estados Unidos
- Canadá
- México
- Europa
- Francia
- Alemania
- Italia
- Reino Unido
- España
- Resto de Europa
- Asia Pacífico (APAC)
- China
- India
- Corea del Sur
- Japón
- Australia
- Resto de APAC
- Oriente Medio y África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de MEA
- América del Sur y Central (SCAM)
- Brasil
- Argentina
- Resto de SCAM
- Getinge AB
- Medtronic
- LivaNova PLC < li>XVIVO Perfusion
- Terumo Cardiovascular Systems Corporation
- OrganOx Limited
- Waters Medical Systems
- TransMedics
- Organ Sistemas de recuperación
- XENIOS AG
Perfiles de empresas
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue. Perfusion is measured as the rate at which blood is delivered to tissue, or volume of blood per unit time (blood flow) per unit tissue mass. During major surgery, perfusion must be maintained and managed by the health professionals involved, rather than left to the body's homeostasis alone.
Key factors that are driving the market are rising prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, rising need for the organ transplantation and rising cell-based research activities. However, challenging factors such as expensive organ transplant surgeries and limited numbers of donors for organ transplant surgeries are likely to show negative impact for the market in few years ahead.
The costs of the medical perfusion technology are much higher, and they may cost US$ 1,0000–5,0000, or more, per software. The cost may also differ from product to product types.
The List of Companies - Medical Perfusion Technology Market
- Getting AB
- Medtronic
- LivaNova PLC
- Terumo Corporation
- XVIVO Perfusion
- OrganOx Limited
- Waters Medical Systems LLC
- TransMedics
- Organ Recovery Systems
- Xenios AG - a Fresenius Medical Care company
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2021
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Mar 2021
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Mar 2021
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)